Cargando…
The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
OBJECTIVE: To assess the outcomes and toxic effects of 5-day actinomycin D (Act-D) salvage therapy and to explore the predictors of Act-D resistance in patients with low-risk gestational trophoblastic neoplasia (GTN)who failed 5-day methotrexate (MTX) chemotherapy. METHODS: This retrospective study...
Autores principales: | Wu, Xiaodong, Qin, Jiale, Shen, Tao, Fei, Weidong, Chen, Lili, Xie, Xing, Lu, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286751/ https://www.ncbi.nlm.nih.gov/pubmed/32026657 http://dx.doi.org/10.3802/jgo.2020.31.e36 |
Ejemplares similares
-
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia
por: Liu, Yuanyuan, et al.
Publicado: (2023) -
Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
por: Agarwal, M, et al.
Publicado: (2022) -
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022) -
Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020) -
The Evolution of Methotrexate as a Treatment for Ectopic Pregnancy and Gestational Trophoblastic Neoplasia: A Review
por: Skubisz, Monika M., et al.
Publicado: (2012)